2VWE
Crystal Structure of Vascular Endothelial Growth Factor-B in Complex with a Neutralizing Antibody Fab Fragment
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SRS BEAMLINE PX14.2 |
Synchrotron site | SRS |
Beamline | PX14.2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2005-09-25 |
Detector | ADSC CCD |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 86.200, 94.300, 91.300 |
Unit cell angles | 90.00, 102.30, 90.00 |
Refinement procedure
Resolution | 19.780 - 3.400 |
R-factor | 0.286 |
Rwork | 0.262 |
R-free | 0.31000 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1CFN AND 2C7W |
RMSD bond length | 0.010 |
RMSD bond angle | 1.400 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | REFMAC (5.2.0005) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 3.610 | 3.600 |
High resolution limit [Å] | 3.400 | 3.400 |
Rmerge | 0.120 | 0.260 |
Number of reflections | 17540 | |
<I/σ(I)> | 7.4 | 2.7 |
Completeness [%] | 93.0 | 72.4 |
Redundancy | 2.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 7 | 0.1 M HEPES PH 7.0 15% GLYCEROL 8% PEG 8000 |